Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2025-12-24 @ 1:04 PM
NCT ID:
NCT04998461
Eligibility Criteria:
Inclusion Criteria - For all participants :
* Age between 18 and 60
* Non diabetic (fasting blood glucose \<1.26 g/L)
* Patient not having objected to participating in the research
Inclusion Criteria - For the obese group with normal renal function
* eDFG ≥ 60 ml/min/1.73 m2
* BMI \> 30 kg/m2
* Microalbuminuria / creatinuria ≤ 3mg / mmol and / or proteinuria \< 0.15 g/24h
Inclusion Criteria - For the obese group with impaired renal function
* eDFG \< 60 ml/min/1.73 m2
* BMI \> 30 kg/m2
* Microalbuminuria / creatinuria ≤ 3mg / mmol and / or proteinuria \< 0.15 g/24h
Inclusion Criteria - For the non-obese group with impaired renal function
* eDFG \< 60 ml/min/1.73 m2
* BMI between 18 and 30 kg/m2
* Microalbuminuria / creatinuria ≤ 3mg / mmol and / or proteinuria \< 0.15 g/24h
Inclusion Criteria - For the non-obese group with normal renal function (control group)
* eDFG ≥ 60 ml/min/1.73 m2
* BMI between 18 and 30 kg/m2
* Microalbuminuria / creatinuria ≤ 3mg / mmol and / or proteinuria \< 0.15 g/24h
Exclusion Criteria - For all participants :
* Acute renal failure within 3 months (defined as an increase of more than 50% in usual creatinemia)
* Inflammatory, infectious, cardiovascular or progressive neoplastic disease
* Urinary pathology (malformation, infection, etc.)
* Exclusion period of a previous study or already participating in a clinical research protocol having an impact on the judgment criteria of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT04998461
Study Brief:
Protocol Section:
NCT04998461